All News Crossject

Equities

Real-time Euronext Paris Other stock markets 05:57:55 2024-05-06 EDT			5-day change	1st Jan Change
2.24 ^EUR	+0.45%		+8.47%	-54.93%

05-03	Crossject: praised for extended agreement on Zepizure	CF
05-02	Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	CI

Crossject: praised for extended agreement on Zepizure	05-03	CF
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	05-02	GL
Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	05-02	CI
CROSSJECT : We welcome the securing of the group’s financial needs	05-02	AL
Crossject reports audited financial results for 2023	04-25	GL
CROSSJECT : Patience is a virtue… hopefully	04-03	AL
Crossject trading on Euronext to resume as usual on Wednesday April 3	04-02	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	04-02	GL
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	04-02	CI
Crossject gender equality score reaches 96/100 in 2024	03-08	GL
Crossject gender equality score reaches 96/100 in 2024	03-08	AQ
CROSSJECT : Invest Securities slightly reduces its target	02-28	CF
CROSSJECT : Securing the financing needs	02-28	AL
Crossject: share price falls after convertible bond issue	02-27	CF
Crossject obtains a financing up to €12 million, in two tranches	02-27	GL
Crossject obtains a financing up to €12 million, in two tranches	02-27	AQ
Crossject Société Anonyme announced that it expects to receive ?12 million in funding	02-25	CI
CROSSJECT : No news is not always good news...	02-08	AL
Crossject: strategy advances, but visibility worries	02-07	CF
Crossject provides strategic update on priorities for 2024	02-06	GL

No results for this search